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Two cell surface molecular structures participate in the specific recognition of a
vast number of different peptide antigens byT lymphocytes. MHC-encoded mole-
culesbind peptide fragments of antigenic material in an antigen binding groove (1).
OnT cells, TCR, predominantly ofthe ac/o chain variety, specifically recognize the
antigenic peptidepresentedbyMHC-encoded molecules (2) . MHC-encoded mole-
cules are extremely polymorphic within a species . This variability probably serves
to safeguard the species against microorganisms that mutate producing peptide an-
tigens no longer boundbyagiven allelic product of aMHC molecule, thus threatening
to evade immune recognition . SinceTCRs may be subject to similar evolutionary
pressures, it is of interest to determine whether polymorphic gene products are ex-
pressed.
Several RFLP of the various human TCR genes have been described (3-5) . In
addition, an expressedpolymorphicTCR determinant recognized byamAb, termed
OT145 (6), suggested thepresence ofTCR allotypes . ThemAbOT145 distinguishes
random individuals on the basis of the percentage of T cells staining with the anti-
body. In one group of individuals (+/+), a mean of 4.5% ofT cells are positive,
in a second group (+/-), 2.04% are positive, and in a third group (-/-) positive
T cells are difficult to detect by the methods used (6) . Ethnic background correlates
strongly with these groups, and in family studies the antibody-defined phenotypes
are inherited consistent with autosomal co-dominant transmission of two different
alleles : the "+" allele recognized by GT145, andthe"-" allele notrecognized byOT145 .
Possibilities forthe absence of reactivity with OT145included (a)amutation leading
to chain termination or a defective promoter both resulting in a pseudogene, (b)
a mutation resulting in an altered epitope at the site recognized by OT145, (c) germ-
line gene deletion, and (d) somatic events resulting in the absence ofOT145+ cells .
In view of thesmallpercentage ofTcells staining with CT145, aVorJregion deter-
minant was suspected.
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Materials and Methods
Family Studies.
￿
Five RFLPs were used to obtain the a chain haplotypes: Bgl II with a
Hind III/Eco RI fragment of the Y14 probe (3' Ca region probe); Msp I and Taq I, both
with a PvuII/Pvu II fragment ofY14 (Ca region probe); Taq I with an Eco RI/Ava I fragment
of Y14 (Va region probe); Msp I and Pvu II both with the VR5 Va region probe (3). Six
RFLPs were used to obtain the /3 chain haplotypes: Bgl II with a C(3 probe derived from
YT35; Hind III and Barn HI with a murine C5V probe; Bam HI with a V/3 probe derived
from YT35 ; Taq I and Pvu II both with the V097 probe (7-9). The ti chain haplotypes were
obtained with Pvu II and a C-y probe as described (5). The ti chain haplotypes in family
S have been published elsewhere (5).
Cloning Strategy.
￿
The OT cDNA library was prepared by modification of the method of
Gubler and Hoffman (10). Poly(A)' RNA from OT leukemia cells was isolated by the
guanidinium/CsCl method and passaged over an oligo(dT) cellulose column. First-strand
cDNA synthesis was carried out with avian myeloblastosis virus (AMV) reverse transcriptase
on 800 ng poly(A)' RNA. Second-strand synthesis was carried out with RNase H and Esch-
erichia coli DNA polymerase I. Blunt ends were prepared with T4 DNA polymerase. Internal
Eco RI sites were protected by Eco RI methylase. Kinased Eco RI linkers (New England
Biolabs, Beverly, MA) were then ligated onto the cDNA, and the resulting product was digested
with Eco RI to produce Eco RI cohesive ends. The cDNA was separated from free linkers
by passage over a Sephadex G-50 column and then directly ligated to Eco RI cut, dephos-
phorylated Xgt10 vector at a molar ratio of 1 :2 . The ligation products were packaged in vitro
by standard techniques usingE. coli C600 hfl strain as a bacterial host. The OT cDNA library
contained 3 .4 x 105 plaque-forming units and was screened with a probe consisting of a 140-
bp Pvu II-Bgl II fragment derived from the constant region of a human TCR /3 chain cDNA
clone (Jurkat 2) provided by Dr. T Mak (Hospital for Sick Children, Toronto, Ontario,
Canada). Positive plaques from the OT cDNA library were subcloned into Eco RI-digested,
phosphatase-treated pIBI 31 vector (International Biotechnologies, Inc., New Haven, CT) .
The purified plasmid was prepared according to Holms and Quigley (11) with modifications.
The sequencing reaction was carried out by the dideoxy chain termination method ofSanger
et al. (12), using both T3 and T7 universal primers (Stratagene, Inc., La Jolla, CA) and a
DNA sequencing kit (Pharmacia/LKB Biotechnology, Inc., Piscataway, NJ).
Polymerase Chain Reaction (PCR).
￿
Peripheral blood T cells from a normal OT145 +/+ in-
dividual were stimulated with OT145 mAb (1 :20 dilution of supernatant) and 10% IL-2 was
added twice a week over 2 wk as described (13). The resultant cell line consisted of >95%
OT145' T cells as analyzed by immunofluorescence. RNA was isolated from 5 x 10' cells
(yield 30 ug) and first-strand cDNA synthesis was accomplished by adding the C region primer
(II) to 10 AM, dNTPs to 1 mM, sodium pyrophosphate to 4 mM, RNAsin 12 U, reverse
transcriptase 50 U (Pharmacia Fine Chemicals) in a final reaction volume of0.02 ml Tris/HCl
50 mM, MgC12 10 mM at pH8.3. The reaction was incubated at 43'C for 30 min. One-
fourth ofthis reaction was then used for the PCR reaction with dNTPs (200 AM each), primers
I and II at 1 PM each, Taq polymerase 2.5 U, in a 0.1-ml reaction volume with 50 mM KCI,
10 mM Tris HCl, pH 8.3, 1.5 MgC12, 0.01% (wt/vol) gelatin. The amplified material ob-
tained after 30 cycles ofautomated PCR hybridized strongly with a VS6.7 probe (Ph79) but
not with a V/38.1 probe by Southern blotting, suggesting that the majority of the amplified
material contained V06 gene segments. In other experiments, RNA isolated from 5 x 10'
fresh unselected T cells from two OT145 -/- individuals was used as template for first strand
cDNA synthesis and PCR amplification of V(36 genes as described above. Similar PCR reac-
tions were also performed with 100 ng germline DNA from an OT145 -/- individual as
template and with DNA eluted from the 12-kb band of an agarose gel loaded with Barn
HI-digested germline DNA from an OT145 -/- individual and using primers III and IV.
PCR products were cloned into the polylinker ofa sequencing vector (pIBI31) using restric-
tion enzyme sites added to the 5' ends of the primers used for the PCR as previously de-
scribed (14). The primer sequences were: I: 5' CGGAATTCAGGTGTGATCCAATTTC 3'
(sense), II: 5' CGGTCGACCTCGGGTGGGAAC 3' (antisense), III: 5' GCGAATTCACC-
AGGCTCCTCTTCT 3' (sense), IV. 5' CTGAATTCACAGAGATACACGGCC 3' (antisense).Southern Blotting .
￿
DNAwasisolated from EBVtransformedcelllinesfrom each individual
bystandard methods (5). 10jugDNAwas digested withBamHIorotherrestrictionenzymes
and loaded on a 0.8% agarose gel. Theblot was hybridized with a 32P-labeled probe corre-
sponding to the 5' 108nucleotidesoftheOT-1 clone(Eco RI-Bst XI fragment). Afterhybrid-
ization, the blot was washed twice in 0.1 x SSC, 0.1% SDS at 65°C for 30 min.
Results and Discussion
Initiallyweperformed family studies with several RFLPs ofthe a, /3, and y chain
TCR genes. Haplotypes for these genes could be assigned as previously described
(3, 5, 7) and summarizedin Fig. 1. TCRgene haplotypes were compared with HLA
haplotypes, obtained by routine serologic typing ofthe family members and to the
OT145-defined phenotype. In family A, only the /3 chain haplotypes correlate with
OT145 phenotypes. For instance, the maternal (3 chain "D" haplotype matches with
the "-" allele. This is consistent with an OT145 determinant encoded by a (3 chain
gene. Infamily S, foursiblings are HLAidentical (Sl, S2, S3, S6); yet all threepheno-
types defined by OT145 are represented among these individuals, suggesting that
HLA type does not influence expression ofthe OT145 TCR in this family. In mu-
rine systems, MHC-encodedproducts, probablyin associationwithcertain autoan-
tigens, may determine TCR V gene usage by causingclonal deletion ofT cells ex-
pressing a TCR with the autoreactive V gene product. Thus for example, IE+
mousestrainshave clonally deletedV017aexpressing T cells(15, 16). The variations
in the percentages of OT145+ cells are apparently due to a different mechanism.
To determine which gene encodes the OT145 polymorphic determinant, a cDNA
library wasconstructedfromtheOTleukemia cells that had served as theimmunogen
to produce the mAb (6). The library was screened with a/3 chain probe containing
C region sequences. A positive clone (OT1) was selected for further study. It con-
tained 252 nucleotides, ofwhich 81 were in the C region, 65 in the D-j region, and
106 in theVregion (Fig. 2). UsingOT-1 as a probe, anotherclone, OT-2 (196 nucleo-
tides), was obtained, which contained only V region sequences, partially overlap-
ping with OT-1 (Fig. 2). From these sequences, it is apparent that the OT leukemic
T cell has a functional rearrangement ofV06.7, D/31.1, andjfl.3 and uses the Col
gene for its TCR (3 chain. The V06.7 sequences ofOT-1 and OT-2 are identical to
LI ET AL.
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FIGURE 1. Results of RFLP
typing of two families are sum-
marized and comparedwiththe
OT145 defined phenotypes and
HLA haplotypes obtained by
routine serologic typing. By
convention, "a" and "b" denote
the paternal, and "c" and"d" the
maternal haplotypes. The cap-
italized haplotypes indicate
matching with the OT145 defined
"= allele. Individuals with <0.5%
OT145* T cells are typed as
-/-, those with up to 3.0%
OT145* T cells as +/-, and
those with over 3.0% OT145*
as +/+ (6).
1 Family S F M S1 S2 S3 S4 S5 so
OT145 phenotype +/.
OT145t T cells (%): 2.2 2.3 3.5 1 .7 <0.1 <0.1 1.2 1.8
2.3 3.5 1.9 <0.1 <0.1 1.2
_3.0
HLA ab cd be be be bd ac be
TCR a-chain ab cd bd ac be bd bd
TCR,8-chain Ab Cd Ad bC AC AC bC bC
TCR --chain ab cd ac ac ac ac be bd
Family A F M Sl S2 S3 S4 S5
OT145 phenotype: +/+ +/- +/+ +/- +/+ +/- +/-
OT145+ T cells (%): 3.3 2.8 3.7 2.7 3.3 2.8 1 .7
3.8 3.4 2.8 3.8 2.7 1.8
HLA ab cd be b c/d bd bd ad
TCR a-chain ab cd bd be ac ac bd
TCR ,9-chain ab cD ac aD ac al) bD224
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three reported VS6.7 sequences (17, 18), of which one represents the V(3 of an au-
toreactive T cell clone, UA-S2. This clone is positive with the mAb OT145 (Schlesier,
M., personal communication).
Nine differentV gene sequenceshave been classified as members ofthe V06 gene
subfamily (19). Some of these sequences differ by only a few nucleotides and could
be allelic products of the same gene. To determine which products of these genes
are recognized by OT145, OT145` cellswere expanded from fresh T cells by adding
the mAb with IL-2 to the cultures (13). After 3 wk, a cell line was obtained con-
taining 95% OT145 T cells as assayed by immunofluorescence. Cytoplasmic RNA
wasisolated andafirst strand cDNA copy was synthesizedwith reversetranscriptase
and then amplified using the PCR. The primers used for the PCR (primers I and
II, Fig. 2) represent a downstream C region sequence and an upstream V06 se-
quence that is common to all known V06 genes. Thus it was expected that any V06
genes transcribedin this cell line wouldbe amplified. Seven clones that were positive
by hybridization with a V06 probe were isolated. Five of these clones have been
sequenced; four have Vf36 .7 sequences (Fig. 2), and one has aV06.3 sequence (Fig.
2; data not shown). OT1, PCRclone 1, and UAS2, all derived from OT145* T cells,
contain different D andJ regions (Fig. 2), suggesting that these regions do not en-
code the OT145 determinant. Thus the combined data suggest that V06.7 is the
predominant (althoughpossibly not theonly) gene encoding theOT145determinant.
To further confirm these results, Southern blots of genomic DNA from individ-
uals typed with the OT145 antibody were performed. The CT-1 clone was digested
with Bst XI, which cuts this clone in two fragments at the VD junction. The resul-
tant 108-bp V region probe hybridizes to the downstream portion of VQ6.7 genes,
and crosshybridizes only minimally with other V(36 genes under high stringency
conditions. Several restriction enzymes (Pvu II, Hind III, and Bam HI) revealed
polymorphic sites in thevicinity ofthe V06.7 gene usingthis probe. Barn HI, which
has a site within the Va6.7 gene (Fig. 2) was chosen for further study. The CT-
1-derived V region probe hybridizes predominantly to sequences downstream of
this Barn HI site. From individuals typed as +/+ with the OT145 mAba 4-kb band
was consistently obtained, while -/- individuals had a 12-kb band and heterozy-
gous individuals hadboth bands (Fig. 3). This analysis wasextended to 36 unrelated
individuals with similar results (Table I). Including the members of family S, 42
individuals were screened by Southern blotting with only two individuals in which
the RFLP analysis did not match the phenotype obtained with OT145. One such
case is sibling 1 in family S where the antibody typing suggested a +/+ genotype,
although one value of 3.0% OT145+ T cells was borderline (Fig. 1). The Bam HI
RFLP, however, typed this individual as heterozygous (4- and 12-kb bands). TCR
/3 chain haplotypes matchedthe OT145phenotypes in allbut sibling 1 in this family.
Such cases could be explained by variations in the percentages of peripheral blood
OT145+ T cells due to extraneous influences such as an ongoing immune response.
Fig. 3 also demonstrates a second allelic system represented by 4.7-kb and 5.8-kb
bands. Presumably these represent two alleles of another V06 gene that is closely
related to V/36.7 and crosshybridizes under the conditions used. This allelic system
represents a fortuitous control since it is not related to the OT145-defined pheno-
types (Table 1). Homozygotes for the 5.8-kb band are most frequent, followed by
heterozygotes (4.7- and 5.8-kb bands), and only two individuals were found to be226
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TABLE I
Distribution of V,B6 Alleles in OT145-defined Groups
FIGURE 3 . Southern blot of
Barn HI-digested germline
DNA from unrelated individ-
uals with different OT145 de-
fined phenotypes (+/+, -/-,or
+/-). B, Barn HI site ; B', poly-
morphic Barn HI site respon-
sible for 4-/12-kb RFLP .
homozygotes forthe 4.7-kb band . The distribution of these bands is similar among
OT145 +/+ and -/- individuals. In contrast the 12-/4-kb Bam HI RFLP matched
closely with the OT145phenotype (Table I) . Thesedata are also consistent with results
demonstrating that RFLP-defined alleles of different genes within a TCR haplo-
type, such as the a chain locus, are not necessarily concordant in population studies
(3, 7) .
Southern blots ofDNA digested with BamHI as well as other enzymes showed
equal numbers of bands in OT145 +/+ and -/- individuals . Thus a deletion of
the V06.7 gene cannot explain the negative staining with OT145 .A mutation resulting
in a nonexpressed pseudogene, as described in the mouse (20), remained a possi-
bility. Therefore the Va6.7 gene was amplified by PCR directly from the germline
OT145
phenotype n 12/12 kb 12/4 kb
Bam
4/4 kb
HI RFLPs
5.8/5.8 kb 5.8/4.7 kb 4 .7/4 .7 kb
OT145 +/+ 17 0/17 1/17 16/17 12/17 5/17 0/17
OT145 + / - 4 0/4 4/4 0/4 1/4 2/4 1/4
OT145-/- 15 15/15 0/15 0/15 11/15 3/15 1/15LI ET AL.
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DNA ofanOT145 -/- individual. The primers used (Fig. 2) represent a 3' region
of the V06.7 gene (primer IV) and a 5' region in the leader sequence (primer III).
Three independentclones were sequenced and revealed identical nucleotide sequences
(GL-PA in Fig. 2). We termed this sequence "V06.7b," in contrast to the original
sequence, now termed "V06.7a" In V06.7b, a Gto A substitution results in aboli-
tionofthe internal Barn HI restriction enzyme site (Fig. 2), which is the most prob-
able explanation for the Barn HI 4-/12-kb RFLP shown in Fig. 3. In +/+ individ-
uals, probes 5'tothissitehybridizetoan8- or a 12.5-kb fragment (datanot shown).
Together, the 4- and 8-kb fragments represent the 12-kb band ofthe "-" allele. The
Barn HI site defining the 5' margin ofthe 12- and 8-kb fragments appears itself to
be polymorphic. Toconfirmthis interpretation, the 12-kb band(derived from a"-/-"
individual) was excised from an agarose gel and the eluted DNA was used as a tem-
plate for PCR with primers I and IV. The resultant clone had a sequence identical
to V06.7b.
To determine whether V06.7b is a functional gene from which mRNA is tran-
scribed, cytoplasmic RNA was isolated from freshly prepared T cells ofa"-/--" in-
dividual. cDNA was synthesized with reverse transcriptase and PCR amplification
was performedwith primers I and IIto amplify anytranscribedV/06 genes. 10 inde-
pendentclones were sequenced: five had V06.1 sequences, twohadV#6.7bsequences,
and one eachhadVa6.2, V(36.3, and V06.4sequences. Thus, inthisindividual V06.7b
represented thesecond most commonV06gene transcribed. ThetwoV06.7bcDNA
sequences and the Va6.7b germline sequence (GL-PA, Fig. 2) demonstrate no mu-
tation that might result in premature chain termination. In view ofthe frequency
ofV06.7b cDNA clones, V06.7b appears to be capable of producing a functional
message.
Two nucleotide differences between V06.7aand V06.7b result in nonconservative
amino acid substitutions while the third is located in the intron (Fig. 2). In the V
region encoded by V06.7b residue 38 is changed from a serine to an asparagine
and residue 72 is changed from a glycine to a glutamic acid. These residues both
represent putative framework residues with high residue variability and high ex-
posure to solvent (21, 22). This is consistent with the fact that both sites contain
charged amino acids in the V06.7b allele, which are unlikely to be buried residues.
Position 38 is thought to be located at the margin of a (3-pleated sheet and facing
the a chain V domain (22). Position 72, however, represents the hairpin bend be-
tween 0 strands E and D and is probably located close to or at the antigen/MHC
binding site (22). Therefore, substitution ofa glutamic acid for a glycine atthis site
may influence Ag/MHC binding. Whether binding of the OT145 mAb is depen-
dent on position 38, position 72, or both is not evident from our data. However,
the epitope recognized by the mAb represents a true allotype ofa TCR Vregion.
OT145 is one of only four similar mAbs to different human TCR V regions that
we have studied. If one-fourth of such antibodies to TCR V region determinants
detect polymorphic determinants, allelic polymorphism of TCR V genes may be
afrequentphenomenon. In supportofthis, evidence for polymorphic Vol products
has also been obtained (23).
MHC-encoded moleculesexhibit polymorphisms withnumerous alleles. In com-
parison, the description oftwo alleles ofV06.7 may seem modest . However, a high
frequency ofgenetic recombination has been observed in TCR gene complexes (3).228
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In addition, our data do not exclude further allelic products ofV06.7 . Microsatellite
regions, such as the (GT)n repeat found in the V#6.7 intron, have been found to
be associated with abundant polymorphism, 4-11 different alleles in one study (24,
25). These interesting (GT)n repeats are identical to zDNA forming sequences (26,
27), may be associatedwith hot spots for recombination (28-30), or may participate
in gene regulation(31, 32). The Vf6.7b (GL-PA) sequence has a deletion of 12 nucleo-
tides from this region: i.e., (gt)15 instead of the (gt)21 observed in the V06.7a se-
quence of UA-S2 (Fig. 2). This is consistent with observations on the polymorphic
nature of these (gt)n repeat sequences (24, 25) .
In view of the absence of somatic mutation in the TCR V genes, TCR V gene
allelic products may play a role in increasing the repertoire for the species and for
heterozygous individuals. In addition, the finding ofTCR V region polymorphisms
has two important predicted consequences. First, there should be immune responses
under control of TCR V genes, an example of which has already been described
(33). Second, disease associations with TCR V genes would be expected (34), pos-
sibly due to differences in key residues in the TCR antigen/MHC binding site.
Summary
Polymorphisms ofhuman TCR gene products have been suggested by the descrip-
tion of a mAb, OT145, that identifies a subset of TCRs in some individuals but
not in others (6). Here we demonstrate that this mAb detects a TCR allotype of
the V06.7 gene. Two allelic products of this V gene differ by two nonconservative
amino acid substitutions. The mAb OT145 appears to react with V06.7a gene prod-
ucts ("+" allele), but not with V06.7b gene products allele). This represents the
first direct demonstration that TCR V gene allotypes exist and provides a possible
explanation for immune responses under the control of TCR V genes and for dis-
ease associations with TCR V genes.
We thank Drs. Tak Mak, Dennis Y. Loh, and Jeffrey P Tillinghast for providing probes.
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